Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Argus Health
Healthtrust
Boehringer Ingelheim
Citi
Deloitte
Express Scripts
Harvard Business School
Dow

Generated: January 19, 2018

DrugPatentWatch Database Preview

ERYTHROMYCIN STEARATE Drug Profile

« Back to Dashboard

Which patents cover Erythromycin Stearate, and when can generic versions of Erythromycin Stearate launch?

Erythromycin Stearate is a drug marketed by Ani Pharms Inc, Lederle, Mylan, Purepac Pharm, and Watson Labs. and is included in seven NDAs.

The generic ingredient in ERYTHROMYCIN STEARATE is erythromycin stearate. There are one hundred and one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.

US Patents and Regulatory Information for ERYTHROMYCIN STEARATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061461-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061505-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 063179-001 May 15, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061505-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061591-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ani Pharms Inc ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 061461-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062089-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062089-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062121-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ERYTHROMYCIN STEARATE erythromycin stearate TABLET;ORAL 062121-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
AstraZeneca
Cipla
Mallinckrodt
Federal Trade Commission
Argus Health
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot